Overview
- 165 inspections across 161 sites are on record.
- 165 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-01.
At a glance
Inspections
165
Sites
161
Observations
165
Career since
Oct 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Apothecon Pharmaceuticals Private Limited | 1 May 2026 | Human Drugs | On file |
| INNOXEL LIFESCIENCES PRIVATE LIMITED | 20 Apr 2026 | Animal Drugs & Feeds | On file |
| Fagron Analytical Services, LLC | 26 Mar 2026 | Human Drugs | On file |
| Staska Pharmaceuticals, Inc. | 20 Feb 2026 | Human Drugs | On file |
| Nice-Pak Products, LLC | 5 Feb 2026 | Human Drugs | On file |
Sites inspected
Apothecon Pharmaceuticals Private LimitedTaluka Padra, Vadodara, India1 insp.
INNOXEL LIFESCIENCES PRIVATE LIMITEDKotambi, India1 insp.
Fagron Analytical Services, LLCWichita, United States1 insp.
Staska Pharmaceuticals, Inc.Bennet, United States1 insp.
Nice-Pak Products, LLCSaint Louis, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Lisa L Flores16 shared
Kimberlee A Ewing16 shared
Ashlee M Ward11 shared
Vanessa J Stefka10 shared
Heath W Cartwright8 shared
Eric D Bowles4 shared
Kevin A Beavers4 shared
WenNing Chan3 shared
Alan A Rivera3 shared
Wen Ning Chan3 shared
Full investigator report
Get the verbatim findings behind Chad W Rice's 165 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site